Publicerad: 2020-11-12 14:39 | Uppdaterad: 2020-11-12 14:40

28,3 miljoner från Cancerfonden till forskare i ANA Futura

Stort grattis till de 10 forskare i ANA Futura som fått bidrag från Cancerfonden 2021-2023.

CIM

Forskningsprojekt

Niklas Björkström, Forskare
Titel: "Dissecting immune cell - tumor cell interactions in the cholangiocarcinoma microenvironment"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 4 500 000 kr

 

Benedict Chambers, Forskare
Titel: "Innate lymphocytes in cancer: the role of activation and inhibition"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 2 400 000 kr

 

Hans Gustaf Ljunggren, Professor
Titel: "Continued development and implementation of novel NK cell-based immunotherapies for treatment of human hematological malignancies"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 3 750 000 kr

 

Jakob Michaelsson, Forskare
Titel: "Diversity and Functional Regulation of Tumor-infiltrating Natural Killer Cells in the Human Lung"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 3 000 000 kr

 

Johan Sandberg, Professor
Titel: "The potential of innate-like MAIT cells in cancer: Immunobiology, immunotherapy and immunopathology"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 3 000 000 kr

Labmed

Forskningsprojekt

Mikael Björnstedt, Professor
Titel: "Redoxaktiva selenföreningar i behandlingen av cancer - translationella och kliniska studier"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 3 000 000 kr

 

Helen Kaipe, Forskare
Titel: "Exploring tumor-infiltrating T cells and cancer-associated fibroblasts in the pancreatic tumor microenvironment - the role of chemokines for T cell infiltration"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 2 400 000 kr

 

Anna Pasetto, Biträdande lektor
Titel: "Establishing a platform for the treatment of Hepatocellular Carcinoma using genetically modified T cells"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 2 400 000 kr

 

Matti Sällberg, Professor
Titel: "Genetic vaccines and immune-based therapies to prevent cancer caused by chronic hepatitis B, C and D virus infections: Therapy development and models"
Anslag beviljat: 2021-01-01 - 2023-12-31, totalt belopp: 3 750 000 kr

 

Planeringsgrupp

Jonas Fuxe, Professor
Titel: "Swe-EMT; Svenska nätverket för translationella studier av cell plasticitet och cancer metastasering"
Anslag beviljat: 2021-01-01 - 2022-12-31, totalt belopp: 150 000 kr